Clinical trial

Avonex®: Safety, Blood Levels and Effects

NCT01863069

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Interferon beta 1a Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention (IM) AVONEX® Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Avonex®: Safety, Blood Levels and Effects

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-01-01

PhasePHASE1

Conditions

Multiple Sclerosis (MS)unresolved

Interventions

Interferon beta 1aDRUG

(IM) AVONEX®DRUG

Sponsors & collaborators

Trio Medicines Ltd.lead sponsor

Biogencollaborator

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01863069 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.